In contrast, an increase in CA125 in serum was associated with an increase in malignancy and mortality, suggesting that mutations in MUC16 may affect the structural stability of MUC16, causing the tumor-derived protein to shed from the surface of hepatocarcinoma cells. This evidence concerns the gene MUC16 and neoplasm.